LFMD (LifeMD) Tariff Resilience Score: 6/10 (As of Jul. 01, 2026)


LFMD LifeMD Inc LFMD
76 GF Score
Price $4.54
GF Value $5.71
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is LifeMD Tariff Resilience Score?

LifeMD LFMD +10.06% 76 Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus rates LFMD with a GF Score™ of 76/100 and a GF Value™ of $5.71 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 675 Healthcare Providers & Services companies, LifeMD ranks better than 83.56% on this metric.

LifeMD has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

LifeMD has LifeMD's reliance on imported medical supplies and equipment exposes it to some tariff risks. However, its ability to source from multiple suppliers and adjust pricing provides moderate resilience against tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes LifeMD might have Average Resilient.

LifeMD  (NAS:LFMD) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

LifeMD Tariff Resilience Score Related Terms

LFMD vs SPOK, AMWL, SY: Tariff Resilience Score Comparison

For the Health Information Services subindustry, LifeMD's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeMD Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeMD's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where LifeMD's Tariff Resilience Score falls into.


LFMD
76GF Score
LifeMD Inc LFMD
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
LifeMD (LFMD) has a Tariff Resilience Score of 6 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, LifeMD ranks #111 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is LifeMD's Tariff Resilience Score too high?
LifeMD's current Tariff Resilience Score is 6. Based on the distribution chart, LifeMD ranks #111 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, LifeMD has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LifeMD's Tariff Resilience Score compare to SPOK and AMWL?
According to the Healthcare Providers & Services industry distribution chart, LifeMD ranks #111 out of 675 companies for Tariff Resilience Score. This places LifeMD in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. LifeMD's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeMD stock overvalued right now?
Based on GuruFocus' analysis, LifeMD (LFMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.71, compared to a current price of $4.54 — trading 20.5% below its estimated fair value. The current Tariff Resilience Score is 6. LifeMD's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For LifeMD (LFMD), the current Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeMD (LFMD) Overvalued in 2026?

Based on GuruFocus' analysis, LifeMD stock appears to be undervalued. The current stock price of $4.54 is trading 20.5% below its estimated GF Value™ of $5.71. GuruFocus considers LifeMD to be Modestly Undervalued.

Key valuation signals for LFMD:

  • Tariff Resilience Score: 6
  • GF Value™: $5.71 vs. price of $4.54 (20.5% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the LFMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeMD Business Description

Address 236 Fifth Avenue, Suite 400, New York, NY, USA, 10001
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
76GF Score

Get the complete analysis for LFMD

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.54
Price
$5.71
GF Value